We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPAY
9351
DELISTED
Akros Monthly Payout ETF
MPAY
$638 ﹤0.01%
+25
New +$645
CNTY icon
9352
Century Casinos
CNTY
$34M
$632 ﹤0.01%
195
-215
-52% -$756
XJUN icon
9353
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
$618 ﹤0.01%
16
-1,362
-99% -$52.3K
SYRA
9354
DELISTED
Syra Health Corp. Class A Common Stock
SYRA
$614 ﹤0.01%
+1,491
New +$600
BGMSP
9355
DELISTED
Bio Green Med Solution Inc Preferred Stock
BGMSP
$612 ﹤0.01%
+84
New +$565
RVPHW
9356
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$612 ﹤0.01%
3,734
+3,068
+461% +$518
FLSW icon
9357
Franklin FTSE Switzerland ETF
FLSW
$84.9M
$607 ﹤0.01%
+19
New +$643
NTRP icon
9358
NextTrip
NTRP
$24.9M
$603 ﹤0.01%
100
-4,834
-98% -$14.5K
DTSS icon
9359
Datasea Intelligent Technology Ltd
DTSS
$8.2M
$598 ﹤0.01%
261
-2,854
-92% -$6.73K
SDSTW
9360
Stardust Power Inc Warrant
SDSTW
$598 ﹤0.01%
2,544
-16,531
-87% -$5.63K
ATMCR
9361
DELISTED
AlphaTime Acquisition Corp Right
ATMCR
$596 ﹤0.01%
4,415
-4,839
-52% -$916
MRNOW
9362
Murano Global Investments PLC Warrants
MRNOW
$127K
$596 ﹤0.01%
+2,699
New +$517
NDRA icon
9363
ENDRA Life Sciences
NDRA
$5.84M
$595 ﹤0.01%
+95
New +$633
APM
9364
DELISTED
Aptorum Group
APM
$594 ﹤0.01%
+212
New +$256
CLWT icon
9365
Euro Tech Holdings
CLWT
$11.8M
$582 ﹤0.01%
+419
New +$627
UNL icon
9366
United States 12 Month Natural Gas Fund
UNL
$13.3M
$580 ﹤0.01%
+71
New +$527
AWEG
9367
DELISTED
Alger Weatherbie Enduring Growth ETF
AWEG
$573 ﹤0.01%
23
WBUY
9368
DELISTED
WEBUY GLOBAL LTD. Ordinary Shares
WBUY
$573 ﹤0.01%
3,314
-219,991
-99% -$35.7K
SKOR icon
9369
FlexShares Credit-Scored US Corporate Bond Index Fund
SKOR
$737M
$572 ﹤0.01%
12
-856
-99% -$41.3K
PLMJ
9370
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
$556 ﹤0.01%
+50
New +$553
CHNR icon
9371
China Natural Resources
CHNR
$5.15M
$551 ﹤0.01%
+102
New +$550
REE
9372
DELISTED
REE Automotive
REE
$547 ﹤0.01%
62
+42
+210% +$336
UXOC
9373
FT Vest U.S. Equity Uncapped Accelerator ETF - October
UXOC
$22.3M
$546 ﹤0.01%
+18
New +$555
XBP icon
9374
XBP Global Holdings
XBP
$36.4M
$543 ﹤0.01%
+50
New +$558
WDTE
9375
Defiance S&P 500 Weekly Distribution ETF
WDTE
$67.5M
$543 ﹤0.01%
14
+13
+1,300% +$536

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.